# EDGAR Filing Document

**Accession Number:** 0001962011
**File Stem:** 0001493152-26-002996
**Filing Date:** 2026-1
**Character Count:** 2036
**Document Hash:** 0af028a2447975ac9f7a3aea2ed94b83
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-002996.hdr.sgml**: 20260225

**ACCESSION NUMBER**: 0001493152-26-002996

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260121

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Kairos Pharma, LTD.
- **CENTRAL INDEX KEY:** 0001962011
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 462993314
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 2355 WESTWOOD BLVD. #139
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90064
- **BUSINESS PHONE:** 818-404-5541

**MAIL ADDRESS:**
- **STREET 1:** 2355 WESTWOOD BLVD. #139
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90064

**KAIROS PHARMA LTD.**

2355 Westwood Blvd., #139

Los Angeles CA 90064

(818) 404-5541

January 21, 2026

<u>Via EDGAR</u>

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Kairos Pharma, Ltd.** |
|  | **Registration Statement on Form S-3** |
|  | **File No. 333-292686** |

---

**Acceleration Request**

---

| | |
|:---|:---|
| **Requested Date:** | **January 23, 2026** |
| **Requested Time:** | **9:00 AM** **Eastern Time** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Kairos Pharma, Ltd. hereby requests acceleration of the effective date of its registration statement on Form S-3 (File No. 333-292686) so that it may become effective at 9:00 a.m. Eastern Time on January 23, 2026, or as soon thereafter as is practicable.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| Kairos Pharma, Ltd. | Kairos Pharma, Ltd. |
|  | *<u>/s/ John S. Yu</u>* |
| Name: | John S. Yu |
| Title: | Chief Executive Officer and<br> Chairman of the Board of Directors |

---

cc: Dorsey & Whitney LLP